Stifel Nicolaus Cuts DocGo (NASDAQ:DCGO) Price Target to $5.50

DocGo (NASDAQ:DCGO) had its target price cut by Stifel Nicolaus from $6.50 to $5.50 in a research report report published on Friday morning,Benzinga reports. They currently have a buy rating on the stock.

A number of other research analysts have also weighed in on the stock. Deutsche Bank Aktiengesellschaft lowered shares of DocGo from a “buy” rating to a “hold” rating and cut their target price for the stock from $5.00 to $2.85 in a research report on Friday. Needham & Company LLC cut their target price on shares of DocGo from $7.00 to $4.00 and set a “buy” rating for the company in a research report on Friday. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $4.89.

DocGo Price Performance

DocGo stock opened at $3.09 on Friday. The firm has a market cap of $315.34 million, a price-to-earnings ratio of 11.04, a P/E/G ratio of 14.16 and a beta of 1.00. DocGo has a fifty-two week low of $2.75 and a fifty-two week high of $5.68. The firm has a fifty day moving average price of $4.58 and a two-hundred day moving average price of $4.02.

Insider Activity

In related news, General Counsel Ely D. Tendler sold 23,088 shares of the company’s stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $4.44, for a total value of $102,510.72. Following the sale, the general counsel now owns 175,645 shares of the company’s stock, valued at $779,863.80. The trade was a 11.62 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 2.70% of the stock is owned by company insiders.

Institutional Trading of DocGo

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. JPMorgan Chase & Co. increased its stake in DocGo by 151.1% in the third quarter. JPMorgan Chase & Co. now owns 109,855 shares of the company’s stock valued at $365,000 after acquiring an additional 66,097 shares during the period. Matrix Asset Advisors Inc. NY bought a new stake in DocGo in the fourth quarter valued at about $424,000. Harbor Capital Advisors Inc. increased its stake in DocGo by 144.6% in the third quarter. Harbor Capital Advisors Inc. now owns 968,537 shares of the company’s stock valued at $3,216,000 after acquiring an additional 572,522 shares during the period. WCM Investment Management LLC increased its stake in DocGo by 64.2% in the fourth quarter. WCM Investment Management LLC now owns 4,314,071 shares of the company’s stock valued at $18,637,000 after acquiring an additional 1,687,100 shares during the period. Finally, Barclays PLC increased its stake in DocGo by 279.7% in the third quarter. Barclays PLC now owns 134,923 shares of the company’s stock valued at $447,000 after acquiring an additional 99,387 shares during the period. Institutional investors own 56.44% of the company’s stock.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.